Previous 10 | Next 10 |
home / stock / lsl:cc / lsl:cc news
BOUCHERVILLE, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC (TSXV: LSL) ("the Company" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce the appointment of Mr. Luc Mainville as Senior Vice President and Chief Financial Officer effective Decem...
Revenues of $2.5M, up 25% over the last two quarters of the year; Gross margin of 18.6%, up sharply on last year's negative gross margin of (1%); Adjusted EBITDA 1 of $0.1M compared with negative adjusted EBITDA of $0.9M a year earlier; Projected sequential revenue gro...
BOUCHERVILLE, Québec, Nov. 01, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “ Company ” or “ LSL Pharma Group ”), a Canadian integrated pharmaceutical company, is pleased to announce that further to its press release of Septembe...
BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces today that its subsidiary LSL Laboratory (“LSL”) has receive...
BOUCHERVILLE, Québec, Oct. 18, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL), (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an exclusive agreement with Fera Pharmaceutical...
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “ Company ” or “ LSL Pharma Group ”), a Canadian integrated pharmaceutical company, is pleased to announce that it has retained on October 5, 2023 the s...
BOUCHERVILLE, Québec, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “ Company ” or “ LSL Pharma Group ”), a Canadian integrated pharmaceutical company, announced today that it has entered into an agreement with iA Capit...
43.5% revenue increase to $2.0 million Gross margin of 34%, up significantly from (23%) last year and 19% in the first quarter Adjusted EBITDA 1 loss of $260,000 versus $1.4 million loss last year Shareholders’ equity of $10.5 million and net debt of $7....
BOUCHERVILLE, Quebec, June 20, 2023 (GLOBE NEWSWIRE) -- GROUPE LSL PHARMA INC (TSXV: LSL) - Groupe LSL Pharma Inc. ("the Company" or " LSL Pharma Group "), a Canadian integrated pharmaceutical company, is pleased to announce that its total annual production capacity will be increased by approxima...
BOUCHERVILLE, Quebec, March 14, 2023 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma Group Inc. (the “ Corporation ” or “ LSL Group ”) is pleased to announce the closing of a complementary private placement for gross proceeds of ...
News, Short Squeeze, Breakout and More Instantly...
Bunker Hill Mining Corp. Company Name:
LSL:CC Stock Symbol:
CNQC Market:
BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered priva...
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholder...
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC . (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it has met the closing conditions of a non-brokered private placement for $1,5 million represent...